146 related articles for article (PubMed ID: 38090514)
1. Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer.
Wen Z; Fu F; Zhao Y; Gao Z; Han H; Li H; Ye T; Hu H; Sun Y; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2157-2168. PubMed ID: 38090514
[TBL] [Abstract][Full Text] [Related]
2. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.
Chen T; Zhong Y; Wen J; Deng J; She Y; Zhu Y; Chen Q; Wu C; Hou L; Jiang L; Chen C
JTO Clin Res Rep; 2023 Oct; 4(10):100574. PubMed ID: 37822700
[TBL] [Abstract][Full Text] [Related]
4. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG; Chansky K; Van Schil P; Nicholson AG; Boubia S; Brambilla E; Donington J; Galateau-Sallé F; Hoffmann H; Infante M; Marino M; Marom EM; Nakajima J; Ostrowski M; Travis WD; Tsao MS; Yatabe Y; Giroux DJ; Shemanski L; Crowley J; Krasnik M; Asamura H; Rami-Porta R;
J Thorac Oncol; 2020 Mar; 15(3):344-359. PubMed ID: 31731014
[TBL] [Abstract][Full Text] [Related]
5. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Lee J; Lee J; Hong YS; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Cho J; Kim HK
Ann Surg; 2023 Jun; 277(6):e1355-e1363. PubMed ID: 35166266
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.
Ren Y; She Y; Tang H; Deng J; Jiang G; Wu C; Zhu Y; Zheng H; Chen C
J Surg Oncol; 2022 May; 125(6):1061-1070. PubMed ID: 35099810
[TBL] [Abstract][Full Text] [Related]
7. Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.
Osarogiagbon RU; Faris NR; Stevens W; Fehnel C; Houston-Harris C; Ojeabulu P; Akinbobola OA; Lee YS; Ray MA; Smeltzer MP
J Thorac Oncol; 2020 Mar; 15(3):371-382. PubMed ID: 31783180
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection.
Xie H; Dai C; Gu C; Zhao S; Xu L; Wang F; Gao J; Su H; Wu J; She Y; Ren Y; Wu C; Chen C
J Thorac Oncol; 2024 Jan; 19(1):130-140. PubMed ID: 37567388
[TBL] [Abstract][Full Text] [Related]
10. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
[TBL] [Abstract][Full Text] [Related]
12. Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.
Si H; Xu L; Zhao Y; Su H; Dai C; Xie H; Zhao S; Wu J; She Y; Hou L; Wu C; Zhao D; Chen C;
Ann Thorac Surg; 2024 Mar; ():. PubMed ID: 38499219
[TBL] [Abstract][Full Text] [Related]
13. Reclassifying the International Association for the Study of Lung Cancer Residual Tumor Classification According to the Extent of Nodal Dissection for NSCLC: One Size Does Not Fit All.
Lee J; Hong YS; Cho J; Lee J; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Kim HK
J Thorac Oncol; 2022 Jul; 17(7):890-899. PubMed ID: 35462086
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the non-small cell lung cancer patients with uncertain resection: A population-based study.
Wang X; Cai JS; Yang F
Lung Cancer; 2022 Sep; 171():47-55. PubMed ID: 35917646
[TBL] [Abstract][Full Text] [Related]
15. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis.
Smeltzer MP; Faris NR; Fehnel C; Akinbobola O; Saulsberry A; Meadows-Taylor M; Pacheco A; Ray M; Osarogiagbon RU
JTO Clin Res Rep; 2021 Apr; 2(4):100161. PubMed ID: 34590011
[TBL] [Abstract][Full Text] [Related]
17. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
Ou SH; Zell JA
J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
[TBL] [Abstract][Full Text] [Related]
18. Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study.
Wang W; Chen D; Xi K; Chen Y; Zhang X; Wen Y; Huang Z; Yu X; Wang G; Zhang R; Zhang L
Front Oncol; 2019; 9():642. PubMed ID: 31396479
[No Abstract] [Full Text] [Related]
19. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
20. Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC.
Hamada A; Suda K; Fujino T; Nishino M; Ohara S; Koga T; Kabasawa T; Chiba M; Shimoji M; Endoh M; Takemoto T; Soh J; Yanagawa N; Shiono S; Mitsudomi T
JTO Clin Res Rep; 2022 May; 3(5):100321. PubMed ID: 35574192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
